Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives

Pharmaceutical Biology

Volumn 54, Issue 2, 2016, Pages 189-197

  Rai, Mahendra ^a   Jogee, Priti S ^a   Agarkar, Gauravi ^a   Santos, Carolina Alves Dos ^b  

^a SANT GADGE BABA AMRAVATI UNIVERSITY   (India)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Anticancer; withaferin A; Withania somnifera; withanolides

Indexed keywords

ANTINEOPLASTIC ALKALOID; DOXORUBICIN; METHYLNITROSOUREA; TRIETHYLENE GLYCOL; UNCLASSIFIED DRUG; WITHAFERIN A; WITHANIA SOMNIFERA EXTRACT; WITHANOLIDE; WITHANONE; WITHANOSIDE; ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; DNA FRAGMENTATION; DNA METHYLATION; DRUG RESEARCH; DRUG SAFETY; DRUG SENSITIVITY; DRUG STRUCTURE; EPIGENETICS; GENE CONTROL; METASTASIS INHIBITION; NONHUMAN; PHYTOCHEMISTRY; PLANT LEAF; PLANT ROOT; PLANT STRUCTURES; PROSTATE TUMOR; REVIEW; SPECIES DISTRIBUTION; WITHANIA SOMNIFERA; ANIMAL; CHEMICAL STRUCTURE; CHEMISTRY; DRUG DEVELOPMENT; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; PROCEDURES; TRENDS; WITHANIA;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG DISCOVERY; HUMANS; MOLECULAR STRUCTURE; PLANT EXTRACTS; PLANT LEAVES; PLANT ROOTS; WITHANIA;

EID: 84949444118     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2015.1027778     Document Type: Review

References (74)

1. Antony ML, Lee J, Hahm ER, et al. (2014). Growth arrest by the antitumor steroidal lactone withaferin A in human breast cancer cells is associated with down-regulation and covalent binding at cysteine 303 of b tubulin. J Biol Chem 289:1852-65.
2. Barche S, Kirad SK, Sharma AK. (2014). Withania somnifera (ashwagandha)-An important medicinal plant. Int J Agric Sci Vet Med 2:40-5.
3. Barua A, Bradaric MM, Bitterman P, et al. (2013). Dietary supplementation of Ashwagandha (Withania somnifera, Dunal) enhances NK cell function in ovarian tumors in the laying hen model of spontaneous ovarian cancer. Am J Reprod Immunol 70:538-50.
4. Bhattacharya SK, Goel RK, Kaur R, Ghosal S. (1987). Anti-stress activity of sitoindosides VII and VIII, new acylsterylglucosides from Withania somnifera. Phytother Res 1:32-7.
5. Bhattacharya SK, Muruganandam AV. (2003). Adaptogenic activity of Withania somnifera: An experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 75:547-55.
6. Biswal BM, Sulaiman SA, Ismail HC, et al. (2013). Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther 12:312-22.
7. Bray F, Ren JS, Masuyer E, Ferlay J. (2013). Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer 132:1133-45.
8. Chadha YR. (1976). The Wealth of India, vol. X. New Delhi: Publications and Informations Directorate, CSIR, 582.
9. Chatterjee S, Srivastava S, Khalid A, et al. (2010). Comprehensive metabolic fingerprinting of Withania somnifera leaf and root extracts. Phytochemistry 71:1085-94.
10. Chen LX, He H, Qiu F. (2011). Natural withanolides: An overview. Nat Prod Rep 28:705-40.
11. Choudhary S, Kumar P, Malik J. (2013). Plants and phytochemicals for Huntington's disease. Pharmacogn Rev 7:81-91.
12. Cui ZG, Piao JL, Rehman MU, et al. (2014). Molecular mechanisms of hyperthermia-induced apoptosis enhanced by withaferin A. Eur J Pharmacol 723:99-107.
13. Datta A, Bagchi C, Tripathi SK. (2013). Antidiabetic and antihyperlipidemic activity of hydroalcoholic extract of Withania coagulans Dunal dried fruit in experimental rat models. J Ayurveda Integr Med 4: 99-106.
14. Davis L, Kuttan G. (2000). Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 71:193-200.
15. Esteller M. (2008). Epigenetics in cancer. N Engl J Med 358:1148-59.
16. Fang MZ, Wang Y, Ai N, et al. (2003). Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 63:7563-70.
17. Fini L, Selgrad M, Fogliano V, et al. (2007). Annurca apple polyphenols have potent demethylating activity and can reactivate silenced tumor suppressor genes in colorectal cancer cells. J Nutr 137:2622-8.
18. Gu M, Yu Y, Gunaherath GM, et al. (2014). Structure-activity relationship (sar) of withanolides to inhibit hsp90 for its activity in pancreatic cancer cells. Invest New Drug 32:68-74.
19. Hahm ER, Singh SV. (2013). Autophagy fails to alter withaferin amediated lethality in human breast cancer cells. Curr Cancer Drug Target 13:640-50.
20. Hardeep K, Renu W, Sunil CK, Gurcharan K. (2012). Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One 7: e37080.
21. Jayaprakasam B, Padmanabhan K, Nair MG. (2009). Withanamides in Withania somnifera fruit protect PC-12 cells from beta-amyloid responsible for Alzheimer's disease. Phytother Res 24:859-63.
22. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. (2003). Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci 74:125-32.
23. Jha AK, Jha M, Kaur J. (2012). Ethanolic extracts of Ocimum sanctum, Azadirachta indica and Withania somnifera cause apoptosis in SiHa cells. Res J Pharm Biol Chem Sci 3:557-62.
24. John J. (2014). Therapeutic potential of Withania somnifera: A report on phyto pharmacological properties. Int J Pharm Sci Res 5:2131-48.
25. Jones PA. (2002). DNA methylation and cancer. Oncogene 21:5358-60.
26. Joshi P, Misra L, Siddique LL, et al. (2014). Epoxide group relationship with cytotoxicity in withanolide derivatives from Withania somnifera. Steroid 79:19-27.
27. Kaul MK, Kumar A, Sharma A. (2005). Reproductive biology of Withania somnifera (L.) Dunal. Curr Sci India 88:1375-7.
28. Khanna D, Sethi G, Ahn KS, et al. (2007). Natural products as a gold mine for arthritis treatment. Curr Opin Pharmacol 7:344-51.
29. Khazal KF, Samuel T, Hill DL, Grubbs CJ. (2013). Effect of an extract of Withania somnifera root on estrogen receptor-positive mammary carcinomas. Anticancer Res 33:1519-23.
30. King-Batoon A, Leszczynska JM, Klein CB. (2008). Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 49:36-45.
31. Ku SK, Bae JS. (2014). Antiplatelet, anticoagulant, and profibrinolytic activities of withaferin A. Vasc Pharmacol 60:120-6.
32. Kuboyama T, Tohda C, Komatsu K. (2005). Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144:961-71.
33. Kuboyama T, Tohda C, Komatsu K. (2014). Effects of ashwagandha (roots of Withania somnifera) on neurodegenerative diseases. Biol Pharm Bull 37:892-7.
34. Kulkarni SK, Dhir A. (2008). Withania somnifera: An Indian ginseng. Prog Neuro-Psychopharmacol Biol Psychiatry 32:1093-105.
35. Kumar A, Mir BA, Sehgal D, et al. (2011). Utility of multidisciplinary approach for genome diagnostics of cultivated and wild germplasm resources of medicinal Withania somnifera, and status of new species, W. ashwagandha, in the cultivated taxon. Plant Syst Evol 291:141-51.
36. Kumar P, Kumar A. (2009). Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food 12:591-600.
37. Lee J, Hahm ER, Marcus AL, Singh SV. (2013). Withaferin A inhibits experimental epithelial-mesenchymal transition in MCF-10A cells and suppresses vimentin protein level in vivo in breast tumors. Mol Carcinog. [Epub ahead of print]. doi:10.1002/mc.22110.
38. Lee J, Sherawat A, Singh SV. (2012). Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells. Breast Cancer Res Treat 136:45-56.
39. Li W, Zhao Y. (2013). Withaferin A suppresses tumor promoter 12-O-tetradecanoylphorbol 13-acetate-induced decreases in isocitrate dehydrogenase 1 activity and mitochondrial function in skin epidermal JB6 cells. Cancer Sci 104:143-8.
40. Li Y, Tollefsbol TO. (2010). Impact on DNA methylation in cancer prevention and therapy by bioactive dietary components. Curr Med Chem 17:2141-51.
41. Llanos GG, Araujo LM, Jiménez IA, et al. (2012). Withaferin A-related steroids from Withania aristata exhibit potent antiproliferative activity by inducing apoptosis in human tumor cells. Eur J Med Chem 54: 499-511.
42. Lyko F, Brown R. (2005). DNA methyltransferase inhibitors and the development of epigenetic cancer therapies. J Natl Cancer Inst 97: 1498-506.
43. Malik F, Kumar A, Bhushan S, et al. (2009). Immune modulation and apoptosis induction: Two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera. Eur J Cancer 45:1494-509.
44. Malik F, Singh J, Khajuria A, et al. (2007). A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci 80:1525-38.
45. Maliyakkal N, Udupa N, Pai KSR, Rangrajan A. (2013). Cytotoxic and apoptotic activities of extracts of Withania somnifera and Tinospora cordifolia in human breast cancer cells. Int J Appl Res Nat Prod 6: 1-10.
46. Manoharan S, Kaur J. (2013). Anticancer, antiviral, antidiabetic, antifungal and phytochemical constituents of medicinal plants. Am J PharmTech Res 3:149-69.
47. Maurya R. (2010). Chemistry and pharmacology of Withania coagulans: An Ayurvedic remedy. J Pharm Pharmacol 62:153-60.
48. Mir BA, Koul S, Kumar A, et al. (2010). Intraspecific variation in the Internal Transcribed Spacer (ITS) tegions of rDNA in Withania somnifera (L.) Dunal. Ind J Biotech 9:325-8.
49. Mirjalili MH, Moyano E, Bonfill M, et al. (2009). Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecule 14:2373-93.
50. Mirza S, Sharma G, Parshad R, et al. (2013). Expression of DNA methyltransferases in breast cancer patients and to analyze the effect of natural compounds on DNA methyltransferases and associated proteins. J Breast Cancer 16:23-31.
51. Mishra LC, Singh BB, Dagenais S. (2000). Scientific basis for the therapeutic use of Withania somnifera (Ashwagandha): A review. Altern Med Rev 5:334-46.
52. Nema R, Khare S, Jain P, Pradhan A. (2013). Anticancer activity of Withania somnifera (leaves) flavonoides compound. Int J Pharm Sci Rev Res 21:103-6.
53. Patil D, Gautam M, Gairola S, et al. (2014). effect of botanical immunomodulators on human Cyp3a4 Inhibition: Implications for concurrent use as adjuvants in cancer therapy. Integr Cancer Ther 13: 167-75.
54. Pingali U, Pilli R, Fatima N. (2014). Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants. Pharmacogn Res 6:12-8.
55. Rai M, Acharya D, Singh A, Varma A. (2001). Positive growth responses of the medicinal plants Spilanthes calva and Withania somnifera to inoculation by Piriformospora indica in a field trial. Mycorrhiza 11: 123-8.
56. Ramos S. (2007). Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. J Nutr Biochem 18:427-42.
57. Roy RV, Suman S, Das TP, et al. (2013). Withaferin A, a steroidal lactone from Withania somnifera, induces mitotic catastrophe and growth arrest in prostate cancer cells. J Nat Prod 76:1909-15.
58. Sarkar S, Mandal C, Sangwan R, Mandal C. (2014). Coupling g2/m arrest to the wnt/b-catenin pathway restrains pancreatic adenocarcinoma. Endocr Relat Cancer 21:113-25.
59. Sharma V, Sharma S, Pracheta, Paliwal R. (2011). Withania somnifera: A rejuvenating ayurvedic medicinal herb for the treatment of various human ailments. Int J Pharm Tech Res 3:187-92.
60. Shohat B, Gitter S, Abraham A, Lavie D. (1967). Antitumor activity of withaferin A (NSC-101088). Cancer Chemother Rep 51:271-6.
61. Siddique AA, Joshi P, Misra L, et al. (2014). 5,6-De-epoxy-5-en-7-one-17-hydroxy withaferin A, a new cytotoxic steroid from Withania somnifera L. Dunal leaves. Nat Prod Res 28:392-8.
62. Sinha P, Ostrand-Rosenberg S. (2013). Myeloid derived suppressor cell function is reduced by withaferin A, a potent and abundant component of Withania somnifera root extract. Cancer Immunol Immunother 62: 1663-73.
63. Siriwardne AS, Dharmadasa RM, Samarasinghe R. (2013). Distribution of withaferin A, an anticancer potential agent, in different parts of two varieties of Withania somnifera (L.) Dunal. grown in Sri Lanka. Pak J Biol Sci 16:141-4.
64. Sundari GT, Sudhakaran S, Ganapathi J. (1999). On the occurrence of an additional diploid taxon in Withania obtusifolia Tackh. (Solanaceae) from the natural population of south India. Feddes Report 110: 419-22.
65. Szarc vel Szic K, Op de Beeck K, Ratman D, et al. (2014). Pharmacological levels of Withaferin A (Withania somnifera) trigger clinically relevant anticancer effects specific to triple negative breast cancer cells. PLoS One 9:e87850.
66. Vaishnavi K, Saxena N, Shah N, et al. (2012). Differential activities of the two closely related withanolides, withaferin A and withanone: Bioinformatics and experimental evidences. PLoS One 7:e44419.
67. Ven Murthy MR, Ranjekar PK, Ramassamy C, Deshpande M. (2010). Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: Ashwagandha. Cent Nerv Syst Agents Med Chem 10:238-46.
68. Visweswari G, Christopher R, Rajendra W. (2013). Phytochemical screening of active secondary metabolites present in Withania somnifera root: Role in traditional medicine. Int J Pharm Sci Res 4: 2770-6.
69. Vyas AR, Singh SV. (2014). Molecular targets and mechanisms of cancer prevention and treatment by Withaferin A, a naturally occurring steroidal lactone. Am Assoc Pharm Sci J 16:1-10.
70. Wadegaonkar VP, Wadengaonkar PA. (2013). Withanone as an inhibitor of survivin: A potential drug candidate for cancer therapy. J Biotechnol 168:229-33.
71. Wadhwa R, Singh R, Gao R, et al. (2013). Water extract of ashwagandha leaves has anticancer activity: Identification of an active component and its mechanism of action. PLoS One 8:e77189.
72. Wijeratne EMK, Xu Y-M, Scherz-Shouval R, et al. (2014). Structure-activity relationships for withanolides as inducers of the cellular heatshock response. J Med Chem 57:2851-63.
73. Winters M. (2006). Ancient medicine, modern use: Withania sominfera and its potential role in integrative oncology. Altern Med Rev 11: 269-77.
74. Yang Z, Garcia A, Xu S, et al. (2013). Withania somnifera root extract inhibits mammary cancer metastasis and epithelial to mesenchymal transition. PLoS One 8:e75069.